Greifenhagen, Uta <br/><br/>
Plasma Proteins Modified by Advanced Glycation End Products (AGEs) Reveal Site-specific Susceptibilities to Glycemic Control in Patients with Type 2 Diabetes.  [electronic resource] 

 -  The Journal of biological chemistry  Apr 2016 
 - 9610-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1083-351X 
<br/><br/><label>Standard No.: </label>10.1074/jbc.M115.702860  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Blood Proteins--metabolism<br/>Diabetes Mellitus, Type 2--blood<br/>Glycation End Products, Advanced--blood<br/>Humans<br/>Pilot Projects<br/>Protein Processing, Post-Translational